Akagera Medicines

Website

Developer of novel liposomal formulations of antibacterial drugs intended to treat tuberculosis. The company develops novel liposomal formulations of antibacterial drugs to treat tuberculosis and othe...

Healthcare
Waltham, MA, United States
Founded 2018
16 employees
Website
Valuation
$345M
Market implied
Share Price
N/A
Total Raised
$62.2M
Last Round
N/A
Investors
+2 other investors
View all 2 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock Akagera Medicines's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required